At meeting held on 20 October 2014
Sharon Bio-Medicine announced that the Board of Directors of the Company at its Meeting held on 20 October 2014 has resolved and allotted 1,61,11,000 Warrants to the Promoter group on Preferential basis in compliance of SEBI (Issue Of Capital And Disclosure Requirements) Regulations, 2009.Powered by Capital Market - Live News
